ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
0.3650
-0.0150 (-3.95%)
At close: Apr 25, 2025, 4:00 PM
0.3614
-0.0036 (-0.99%)
After-hours: Apr 25, 2025, 7:27 PM EDT
ReShape Lifesciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.69 | 4.46 | 3.86 | 22.77 | 2.96 | Upgrade
|
| Cash & Short-Term Investments | 0.69 | 4.46 | 3.86 | 22.77 | 2.96 | Upgrade
|
| Cash Growth | -84.46% | 15.67% | -83.07% | 669.87% | 0.75% | Upgrade
|
| Accounts Receivable | 0.99 | 1.66 | 2.18 | 2.82 | 2.62 | Upgrade
|
| Receivables | 0.99 | 1.66 | 2.18 | 2.82 | 2.62 | Upgrade
|
| Inventory | 2.46 | 3.74 | 3.61 | 3 | 2.24 | Upgrade
|
| Prepaid Expenses | 0.33 | 0.2 | 0.08 | 1.12 | 0.91 | Upgrade
|
| Restricted Cash | 0.1 | 0.1 | 0.1 | 0.05 | 0.05 | Upgrade
|
| Other Current Assets | 0.01 | 0.14 | 0.08 | 0.19 | 0.16 | Upgrade
|
| Total Current Assets | 4.59 | 10.3 | 9.91 | 29.94 | 8.94 | Upgrade
|
| Property, Plant & Equipment | 0.15 | 0.31 | 0.87 | 1.72 | 1.05 | Upgrade
|
| Other Intangible Assets | - | - | 0.26 | 20.83 | 27.02 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.02 | 0.03 | 0.06 | - | - | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 4.79 | 10.66 | 11.14 | 52.53 | 37.06 | Upgrade
|
| Accounts Payable | 2.21 | 1.69 | 1.93 | 3.47 | 3.66 | Upgrade
|
| Accrued Expenses | 0.89 | 0.86 | 2.15 | 2.13 | 2.45 | Upgrade
|
| Current Portion of Long-Term Debt | 0.81 | - | - | - | 3.61 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.11 | 0.17 | 0.28 | 0.31 | Upgrade
|
| Current Income Taxes Payable | 0.03 | 0.06 | 0.12 | 0.33 | 0.27 | Upgrade
|
| Other Current Liabilities | 0.93 | 1.06 | 3.12 | 1.33 | 1.31 | Upgrade
|
| Total Current Liabilities | 4.99 | 3.78 | 7.48 | 7.53 | 11.61 | Upgrade
|
| Long-Term Debt | - | - | - | - | 9.17 | Upgrade
|
| Long-Term Leases | 0.04 | 0.15 | - | - | 0.16 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.37 | 0.62 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.07 | - | 0.3 | 1.02 | Upgrade
|
| Total Liabilities | 5.05 | 4 | 7.48 | 8.2 | 22.57 | Upgrade
|
| Common Stock | - | - | 0 | - | 0 | Upgrade
|
| Additional Paid-In Capital | 642.56 | 642.33 | 627.94 | 622.4 | 529.43 | Upgrade
|
| Retained Earnings | -642.7 | -635.57 | -624.19 | -577.97 | -514.83 | Upgrade
|
| Comprehensive Income & Other | -0.1 | -0.09 | -0.09 | -0.09 | -0.12 | Upgrade
|
| Total Common Equity | -0.25 | 6.66 | 3.66 | 44.33 | 14.49 | Upgrade
|
| Shareholders' Equity | -0.25 | 6.66 | 3.66 | 44.33 | 14.49 | Upgrade
|
| Total Liabilities & Equity | 4.79 | 10.66 | 11.14 | 52.53 | 37.06 | Upgrade
|
| Total Debt | 0.97 | 0.26 | 0.17 | 0.28 | 13.25 | Upgrade
|
| Net Cash (Debt) | -0.27 | 4.2 | 3.68 | 22.49 | -10.3 | Upgrade
|
| Net Cash Growth | - | 13.93% | -83.62% | - | - | Upgrade
|
| Net Cash Per Share | -0.53 | 40.86 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 11.28 | 0.4 | 0.05 | - | - | Upgrade
|
| Total Common Shares Outstanding | 0.73 | 0.4 | - | - | - | Upgrade
|
| Working Capital | -0.4 | 6.52 | 2.43 | 22.41 | -2.66 | Upgrade
|
| Book Value Per Share | -0.35 | 16.47 | - | - | - | Upgrade
|
| Tangible Book Value | -0.25 | 6.66 | 3.4 | 23.51 | -12.54 | Upgrade
|
| Tangible Book Value Per Share | -0.35 | 16.47 | - | - | - | Upgrade
|
| Machinery | 0.15 | 0.15 | 0.94 | 1.36 | 0.34 | Upgrade
|
| Construction In Progress | - | - | 0.07 | 0.41 | 0.4 | Upgrade
|
| Leasehold Improvements | - | - | 0.02 | 0.02 | 0.02 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.